Neurofibromatosis Type 1 Treatments
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
24
NCT06615284
A Study of Atorvo+™ in Healthy Adult Participants
Phase: Phase 1
Role: Lead Sponsor
Start: Nov 18, 2024
Completion: Jul 1, 2025
Loading map...